PMID- 33828374
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240331
IS  - 0976-4879 (Print)
IS  - 0975-7406 (Electronic)
IS  - 0975-7406 (Linking)
VI  - 12
IP  - Suppl 2
DP  - 2020 Nov
TI  - Medication Adherence Assessment Among Patients with Type 2 Diabetes Mellitus 
      Treated Polytherapy in Indonesian Community Health Center: A Cross 
      Sectional-Study.
PG  - S758-S762
LID - 10.4103/jpbs.JPBS_257_19 [doi]
AB  - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic disease where most of 
      the patients usually need polytherapy. This could affect their medication 
      adherence (MA). However, other complex factors may also associate with MA, which 
      are important to identify. AIM: The purpose of this study was to evaluate the MA 
      of patients with T2DM who received polytherapy and to identify other factors that 
      can affect the MA. MATERIALS AND METHODS: This was a cross-sectional study 
      conducted in seven community health centers in Jakarta with HbA(1C) representing 
      their MA level. Poor controlled blood glucose with Hemoglobin A(1C) (HbA(1C)) of 
      >/=7% is indicated to have low MA. All characteristics were collected to identify 
      factors that are potentially associated with low MA. The univariate analysis 
      tests were used to analyze factors that potentially associate with low MA. 
      Multiple logistic regression analysis was performed in the factors to find their 
      relationship with low MA. RESULTS: The study obtained 143 patients with a female 
      dominance (67.8%) and mean +/- standard deviation (SD) age of 59.53 +/- 9.251 years. 
      Approximately 75.5% of the patients had low MA (HbA(1C) >/= 7). Univariate analysis 
      found that duration of T2DM significantly (P = 0.047) related to MA, where 
      patients with T2DM of less than or equal to 5 years tended to have low MA. 
      Logistic regression showed that patients with T2DM less than or equal to 5 years 
      (P = 0.015, odds ratio = 1.206, 95% confidence interval = 1.216-8.014) were 
      associated with low MA. CONCLUSION: Patients with the duration of T2DM less than 
      or equal to 5 years surprisingly were susceptible to have low MA. Low MA was not 
      affected by polytherapy.
CI  - Copyright: (c) 2020 Journal of Pharmacy and Bioallied Sciences.
FAU - Wulandari, Nora
AU  - Wulandari N
AD  - Faculty of Pharmacy and Science, University of Muhammadiyah Prof. DR. HAMKA Jl 
      Delima II/IV Islamic Center, Malakasari, Duren Sawit, East Jakarta, Indonesia.
FAU - Maifitrianti, Maifitrianti
AU  - Maifitrianti M
AD  - Faculty of Pharmacy and Science, University of Muhammadiyah Prof. DR. HAMKA Jl 
      Delima II/IV Islamic Center, Malakasari, Duren Sawit, East Jakarta, Indonesia.
FAU - Hasanah, Faridlatul
AU  - Hasanah F
AD  - Faculty of Pharmacy and Science, University of Muhammadiyah Prof. DR. HAMKA Jl 
      Delima II/IV Islamic Center, Malakasari, Duren Sawit, East Jakarta, Indonesia.
FAU - Atika, Sri
AU  - Atika S
AD  - Faculty of Pharmacy and Science, University of Muhammadiyah Prof. DR. HAMKA Jl 
      Delima II/IV Islamic Center, Malakasari, Duren Sawit, East Jakarta, Indonesia.
FAU - Dini Putri, Risa
AU  - Dini Putri R
AD  - Faculty of Pharmacy and Science, University of Muhammadiyah Prof. DR. HAMKA Jl 
      Delima II/IV Islamic Center, Malakasari, Duren Sawit, East Jakarta, Indonesia.
LA  - eng
PT  - Journal Article
DEP - 20201105
PL  - India
TA  - J Pharm Bioallied Sci
JT  - Journal of pharmacy & bioallied sciences
JID - 101537209
PMC - PMC8021045
OTO - NOTNLM
OT  - Medication adherence
OT  - polytherapy
OT  - type 2 diabetes mellitus
COIS- There are no conflicts of interest.
EDAT- 2021/04/09 06:00
MHDA- 2021/04/09 06:01
PMCR- 2020/11/01
CRDT- 2021/04/08 06:24
PHST- 2019/11/04 00:00 [received]
PHST- 2020/02/16 00:00 [revised]
PHST- 2020/04/01 00:00 [accepted]
PHST- 2021/04/08 06:24 [entrez]
PHST- 2021/04/09 06:00 [pubmed]
PHST- 2021/04/09 06:01 [medline]
PHST- 2020/11/01 00:00 [pmc-release]
AID - JPBS-12-758 [pii]
AID - 10.4103/jpbs.JPBS_257_19 [doi]
PST - ppublish
SO  - J Pharm Bioallied Sci. 2020 Nov;12(Suppl 2):S758-S762. doi: 
      10.4103/jpbs.JPBS_257_19. Epub 2020 Nov 5.